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ONLINE DATA SUPPLEMENT:  METHODS 1 
Hemodynamic and Morphometric Studies on Mice 2 
All the experimental protocols used in this study were approved by the Animal Care 3 
Committee at Stanford University and adhered to the published guidelines of the 4 
National Institutes of Health and the American Physiological Society.   5 
C57Bl6J and C57 ApcMin/+ mice were purchased from the Jackson Laboratory (Jackson 6 
Laboratories, Bar Harbor, ME). All animals used in our experiments were obtained by 7 
crossing male C57 ApcMin/+ mice and a female C57Bl6J for at least five generations.  Tail 8 
based genotyping of the progeny was used to identify littermate controls and ApcMin/+ 9 
mice.  For hypoxia studies, mice were placed in a hypoxia chamber where they were 10 
exposed to 10% inspired O2 with access to food and water ad libitum for 3 weeks.  To 11 
establish the hypoxic environment, the chamber was flushed with a mixture of room air 12 
and nitrogen, and the gas was re-circulated continuously.  The chamber environment 13 
was monitored using an oxygen analyzer (Servomex, Sugar Land, TX).  Carbon dioxide 14 
was removed by soda lime granules and chamber temperature was maintained at 22–15 
24°C.  The chamber was inspected daily to document temperature, O2+CO2 atmospheric 16 
concentration and animal welfare, and was opened every third day for 1 hour to clean 17 
the cages and replenish food and water supplies.  RVSP, RV and heart rate were 18 
measured under isoflurane anesthesia (1.5–2.5% in 2 L O2/min) in unventilated mice 19 
using a closed chest technique as previously described in detail1.  A 1.4-F Millar catheter 20 
(Millar Instruments, Houston, TX) was inserted into the jugular vein and directing to the 21 
right ventricle.  Systemic blood pressure was determined in conscious animals by a 22 
noninvasive computerized tail-cuff method. Pulmonary artery acceleration time (PAAT) 23 
was determined from Doppler echocardiograms acquired with a GE Vivid 7 ultrasound 24 
system (GE Healthcare, Milwaukee, WI) equipped with 13-MHz transducer. The Doppler 25 
sample volume was centrally positioned within the main PA, just distal from the 26 
pulmonary valve with the beam oriented parallel to the flow as described2. The sweep 27 
speed for flow recordings was 200 mm/s. PAAT was defined as the interval between the 28 
onset of systolic pulmonary arterial flow and peak flow velocity3.  LVEDP measurements 29 
were performed under isoflurane anesthesia (1.5% in 1L/min oxygen flow).   A 1.4-F 30 
Millar catheter was inserted into the right carotid artery and advanced into the left 31 
ventricle. Intraventricular pressure signals from Millar transducer were analyzed using a 32 
PowerLab/4sp data acquisition system (AD Instruments Ltd, Castle Hill, Australia) 33 
connected to a ThinkPad computer. Systolic and diastolic left ventricular pressure were 34 
measured directly from the pressure waveforms. Left ventricular shortening fraction and 35 
cardiac output were evaluated by echocardiography (Acuson Sequoia 256, Garnerville, 36 
NY).  The mice were euthanized by exsanguination.  The heart and lungs were removed 37 
en bloc, and right ventricular hypertrophy was evaluated by the Fulton index, i.e., weight 38 
of right ventricle/left ventricle plus septum (RV/LV+S).  The pulmonary circulation was 39 
flushed with 3ml of PBS at 37°C, and the lungs were prepared for morphometric 40 
analyses by barium gelatin injection of the pulmonary arterial vasculature and formalin 41 
inflation-fixation of the lung.  Morphometric analyses were performed on paraffin-42 
embedded lung sections stained using elastic van Giessen or Movat pentachrome 43 
stains.  The total number of peripheral arteries was calculated as a ratio of the number of 44 
arteries per 100 alveoli in each of 5–6 different microscopic fields (200x magnification) 45 
per section from each lung.  Muscularization was assessed in 15 higher magnification 46 
fields/per mouse (400x magnification) by calculating the proportion of fully and partially 47 
muscularized peripheral (alveolar duct and wall) PAs to total peripheral PAs.  All 48 
morphometric analyses were performed by one observer, blinded as to genotype and 49 
condition, i.e., room air, hypoxia, and recovery. 50 
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 1 
Isolation of Mouse and Human Microvascular Pulmonary Endothelial Cells 2 
Mouse mvPAEC were isolated by digesting whole lung tissue with collagenase IA 3 
(0.5mg/ml) for 45 minutes at 37°C.  The cell suspension was filtered through 70µm cell 4 
strainers, and then centrifuged at 250G for five minutes.  The cell pellet was then 5 
washed three times with PBS and the cell suspension was incubated with sheep anti-rat 6 
IgG magnetic beads (Invitrogen, Carlsbad, CA) coated with rat anti-mouse CD-31 7 
antibody (BD Biosciences, San Diego, CA) to select out mvPAEC for culture.  8 
Characterization of the culture after isolation was performed by labeling with Dil-9 
conjugated Ac-LDL (Dil-Ac-LDL) and CD31 staining and confirmed as 95% pure ECs.  10 
Human mvPAEC were isolated from fresh lungs of control (unused donor) and IPAH 11 
patients obtained through the PHBI Network (PHBI).  The tissues were procured at the 12 
Transplant Procurement Centers at Stanford University, Cleveland Clinic and Allegheny 13 
General Hospital and de-identified patient data were obtained via the Data Coordinating 14 
Center at the University of Michigan.  Lung tissue was digested with collagenase IA 15 
(1.0mg/ml) (Sigma-Aldrich, St Louis, MO) for 1h and followed the mouse mvPAEC 16 
protocol.  Anti-human CD31-coated beads were used for EC purification (Cat: 111.55D, 17 
Invitrogen).  To ensure the purity of the culture we re-purified these cultures with CD31 18 
beads after first passage.  Staining using Dil-conjugated Ac-LDL (Dil-Ac-LDL, Invitrogen) 19 
and CD31 show over 95% purity for ECs.  The expression analyses were done at 20 
passage 2.  All cells were used between passages 3 and 6. 21 
 22 
Cell Culture 23 
Primary human mvPAECs and EC growth medium were obtained from Sciencell 24 
(Sciencell, Carlsbad, CA).  Cells were grown in EC growth medium (2% FBS, 1 µg/ml 25 
hydrocortisone, 10ng/ml human epidermal growth factor, 3ng/ml basic fibroblast growth 26 
factor, 10µg/ml heparin, and gentamycin/amphotericin); subcultured at a 1:4 ratio in 27 
100mm dishes (Corning, Lowell, MA) and used between passages 4-8.  Cells were 28 
starved in EC starvation medium (0.2% FBS and gentamycin/amphotericin) for 24 hours 29 
prior to the experiment.  SW480 cells were obtained from ATCC (ATCC, Manassas, VA) 30 
and maintained in Leibovitz F12 media (ATCC).  For hypoxia studies, cells were placed 31 
in an incubator containing a hypoxia chamber (Biospherix, New York, NY) that provided 32 
1% O2 concentration for 24 hours. 33 
 34 
For affinity purification (see “Affinity Purification” below), 293T cells were used and 35 
maintained in DMEM high glucose/10% FCS plus Penicillin/Streptamycin.   36 
 37 
Adhesion Assay 38 
A 96-well plate was coated with fibronectin (purified from human plasma and purchased 39 
from Sigma-Aldrich, St. Louis MO), collagen IV (purified from human fibroblasts and 40 
purchased from Sigma-Aldrich, St. Louis, MO) and laminin (derived from Engelbreth-41 
Holm-Swarm murine sarcoma basement membrane and purchased from Sigma-Aldrich, 42 
St. Louis, MO) overnight at 4oC using concentrations of 1.0, 5.0 and 10.0 µg/ml for each 43 
ECM component per well, respectively.  Human mvPAECs between passages three and 44 
five were seeded (20,000 cells/well) and incubated at 37°C for 30 minutes.  At the end of 45 
the experiment, the cells were washed in PBS and fixed in 4% PFA at room temperature 46 
for 10 minutes.  Subsequently, cells were stained with crystal violet for 10 minutes 47 
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followed by a water wash for 10 minutes. The average number of cells was calculated by 1 
counting the total number of cells in six random fields per well (200x magnification).  All 2 
assays were done in triplicate, and three separate cell harvests were assessed. 3 
 4 
Tube Formation Assay 5 
Human and murine mvPAECs (5×103 per well) were cultured in a 96-well plate (Corning, 6 
Lowell, MA) coated with 50µl Matrigel Basement Membrane Matrix or Growth Factor 7 
Reduced Matrigel (Trevigen, Gaithersburg, MD).  Tube length was quantified after 6 8 
hours by measuring the cumulative tube length in three random microscopic fields using 9 
a Leica computer-assisted microscope with the program KS300 3.0 (Zeiss). 10 
 11 
Integrin Blockade Assay 12 
A 96-well plate was coated with LN overnight at 4oC using a concentration of 5.0µg/ml.  13 
Prior to seeding in the cell culture wells, mvPAECs between passages three and five 14 
were incubated with different integrin blocking antibodies (α1, α2, α3, α4, α5, αV, α6, β1 15 
and β4, Millipore, Billerica, MA) at the following concentrations: 0.1, 0.5, 1.0 and 5 µg/ml, 16 
for one hour at 4oC.  Following integrin blockade, the cells were seeded in the coated 96 17 
well plates and adhesion studies performed as described above. 18 
 19 
Proliferation and Survival assays  20 
To measure proliferation, cells were seeded at 25,000 cells per well on 24-well plates in 21 
EC growth medium and allowed to adhere overnight.  The next day, cells were washed 22 
3x with PBS and incubated in EC starvation medium for 24 hours.  Cells were then 23 
trypsinized and counted in a hemocytometer as previously described4.  All assays were 24 
done in triplicate, and three separate cell harvests were assessed.  For Caspase 3/7 25 
assays, cells were seeded in a 96-well plate (4 wells per condition and 5,000 cells per 26 
well) and allowed to attach overnight, then incubated for 24 hours in serum-free media to 27 
induce apoptosis.  Then cells were incubated for 1 hour in 100µl of Caspase 3/7 28 
Luciferase Reagent Mix (Promega, Madison, WI) and total luminescence measured in a 29 
Turner 20/20 luminometer (Turner Biosystems, Sunnyvale, CA). 30 
 31 
RNA Interference 32 
The siRNA duplexes (Dharmacon, Lafayette, CO) specific for β−catenin (Dharmacon on-33 
target plus; accession number NM_001012329, NM_020248), and APC (Ambion 34 
Validated siRNA, Ambion, Grand Island, NY), were transfected into human mvPAECs 35 
using nucleofection as described previously 4.  Knockdown efficiency was evaluated 48 36 
hours later by measuring protein levels in lysates using a western immunoblot as 37 
described below. 38 
 39 
Plasmids and Transfection Methods 40 
A pCMV-Neo-Bam plasmid containing the H. sapiens WT APC sequence was a kind gift 41 
from Dr. Bert Vogelstein (Johns Hopkins University). A constitutively active (CA) Akt 42 
expression construct (pcDNA3 T7 Akt1 K179M T308A S473A) was a kind gift from Dr. 43 
William Sellers (Novartis). Plasmids containing inserts with the integrin α3 and α4 44 
sequences in a pBluescript II KS phagemid were obtained from ATCC.  Cells were 45 
transfected in a Nucleofector II (Program T-032, Lonza) using the basic endothelial 46 
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Nucleofection Kit (Lonza, Basel, Switzerland).  1 
 2 
Western Immunoblotting  3 
Cells were washed three times with ice-cold PBS and lysates prepared by adding boiling 4 
lysis buffer (10mM Tris HCl, 1% SDS, 0.2mM PMSF) containing 1X protease and 5 
phosphatase inhibitors (Sigma-Aldrich, St. Louis, MO), scraping into a 1.5ml 6 
microcentrifuge tube and boiling for 10 minutes prior to centrifugation.  Protein 7 
concentration was determined by the Lowry assay (Bio-Rad, Hercules, CA).  Equal 8 
amounts of protein were loaded onto each lane of a 4-12% Bis-Tris gel and subjected to 9 
electrophoresis under reducing conditions.  After blotting, PVDF membranes were 10 
blocked for one hour in blocking buffer (nonfat milk powder 5% in TBS/Tween 0.1%) and 11 
incubated with primary antibodies overnight at 4°C.  Binding of secondary HRP-12 
antibodies was visualized by ECL or ECL plus (Amersham Biosciences, Piscataway, 13 
NJ).  A loading control was evaluated by re-probing the membrane with a mouse 14 
monoclonal antibody to α-tubulin (Sigma-Aldrich).  The following antibodies were used to 15 
probe the membranes: β-catenin (BD Biosciences), APC and ILK-1 (Santa Cruz 16 
Biotechnology, Santa Cruz, CA), α1, α3 and α5 integrins (Millipore), phospho and total 17 
Akt (Cell Signaling Technologies, Boston, MA). 18 
 19 
Affinity purification (AP) and mass spectrometry to validate specificity of APC 20 
antibody 21 
For AP, 293T cells were seeded to 20% subconfluence in 15 cm plates. When cells were 22 
attached, cells were transfected with 20 µg pCMV-APC or pCMV empty vector using 23 
calcium phosphate. 48 h after transfection, cells were detached and washed with PBS. 24 
Cells were lysed in 1 ml cold lysis buffer (50 mM Tris pH 7.5, 150 mM NaCl, 1 mM 25 
EDTA, 0.5% Nonidet P40, 2 mM sodium orthovanodate, 2 mM PMSF and HALT 26 
protease inhibitor (Pierce)). Cells were dounced 20x on ice, and spun at 10,000 rpm for 27 
30 min. The supernatant was pre-cleared with 20 µl Dynabeads Protein G (Invitrogen) 28 
for 1 hr. The pre-cleared lysate was incubated with 4 µl of APC antibody (Santa Cruz) 29 
overnight.  The next day the antibody was chased with 40 µl of Dynabeads for 3 hr. The 30 
beads were washed 4 times with lysis buffer but containing 0.05% Nonidet P40. Proteins 31 
were eluted with 50 µl of IgG Elution Buffer (Pierce) for 10 min using gentle vortex. The 32 
IP solution elutes were neutralized with 5 µl of 1M Tris pH 9.0. Half of the elutes were 33 
analyzed by 4% SDS-PAGE (Invitrogen) followed by silver staining (Pierce). Protein 34 
bands were excised and sent to the Stanford University Mass Spectrometry core facility 35 
(Stanford, CA) for analysis. Excised gels were digested using Promega MS grade trypsin 36 
overnight as previously reported (1), with the addition of the acid labile surfactant 37 
protease max (Promega). Prior to digestion the gel slices were cut into approximately 38 
1mm x 1mm cubes, reduced with 5 mM DTT and alkylated with acrylamide. Peptides 39 
were extracted and dried down using a speed-vac prior to reconstitution and analysis. 40 
The remaining IP solution elutes were sent to the SUMS facility. Elutes were digested 41 
using the previously reported FASP (2) protocol using 30 µM filters from Pall.  Nano 42 
reversed phase HPLC was done using an Eksigent 2D nanoLC (Eksigent, Dublin, CA) 43 
with buffer A consisting of 0.1 % formic acid in water and buffer B 0.1 % formic acid in 44 
acetonitrile. A fused silica column self packed with duragel C18 (Peeke, Redwood City, 45 
CA) matrix was used with a linear gradient from 2 % B to 40 % B at a flow rate of 600 46 
nL/minute. The nanoHPLC was interfaced with a Bruker/Michrom Advance Captive 47 
spray source for nanoESI into the mass spectrometer. The mass spectrometer was a 48 
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LTQ Orbitrap Velos (Thermo Fischer Scientific) which was set in data dependent 1 
acquisition mode to perform MS/MS on the top twelve most intense multiply charged 2 
cations. The .RAW data were searched using Sequest on a Sorcerer platform against 3 
the Uniprot database. Data was validated and visualized using Scaffold software. 4 
 5 
Confocal Microscopy 6 
Cells were plated in four-chamber polystyrene glass slides (15,000 cells per chamber).  7 
For stimulation studies, cells were starved for 48 hours and then stimulated with BMP-2 8 
as specified.  Next, cells were fixed for ten minutes in 4% paraformaldehyde followed by 9 
three washes with PBS.  Cells were permeabilized for 30 minutes on room temperature 10 
with 0.1% triton X-100 and 1% BSA in ice-cold PBS prior to overnight incubation with 11 
primary antibody.  The next day, samples were washed in PBS three times and 12 
incubated with Alexa 488 or 555 tagged secondary antibody (Molecular Probes, 13 
Carlsbad, CA) for one hour at room temperature.  For actin labeling studies, slides were 14 
treated with Alexa 488 labeled phalloidin for 20 minutes to stain for actin followed by 15 
addition of Gold Antifade solution containing DAPI (Molecular Probes) and stored at 4°C 16 
until analysis. 17 
Confocal analysis was performed using a Leica SP2 AOBS confocal laser scanning 18 
microscope using HCX PL APO 63X oil objective (N.A. 1.32-0.60) to locate areas of 19 
interest on the slides.  Image acquisition was performed using the Leica Confocal, v 2.5, 20 
build 1347 software.  Images were processed and saved in TIFF format using Adobe 21 
Photoshop Creative Suite 2 (Adobe Systems, San Jose, CA). 22 
 23 
ILK-1 Kinase Assay 24 
Cells were starved for 48 hours prior to the experiment. Cells were washed in PBS and 25 
lysed with ice-cold RIPA buffer (500ml per T75 flask).  Equivalent amounts (250 µg) of 26 
lysates were incubated overnight at 4°C with 5 µl of goat polyclonal anti-ILK1 antibody 27 
(Santa Cruz Biotechnology).  The next day, the immune complexes were precipitated 28 
with protein G sepharose 4 fast flow beads (Amersham) and washed three times with 29 
RIPA lysis buffer and three times with kinase buffer (50mM HEPES [pH=7], 2mM MgCl2, 30 
2mM MnCl2, 20mM Na3VO4, protease inhibitors).  The kinase assay was performed 31 
using 2µg of GSK3β fusion protein (Cell Signaling Technologies, Boston, MA) as a 32 
substrate.  This fusion protein is a low molecular weight (~28kDa) peptide that contains 33 
the two serine residues (Ser21/9) which undergo phosphorylation in the presence of ILK-34 
1. GSK3β fusion protein is then incubated with 200µM ATP in the reaction buffer (50mM 35 
HEPES [pH=7], 2mM MgCl2, 2mM MnCl2, 20mM Na3VO4, 20mM NaF) for 30 minutes at 36 
30°C.  Next, Laemmli buffer was added and samples were boiled for 10 minutes prior to 37 
loading onto a 4-12% Bis-Tris SDS-PAGE gel.  Phophorylation of the substrate was 38 
detected by western immunoblot with anti-GSK3β serine 21/9 antibodies (Cell Signaling 39 
Technologies). 40 
 41 
 42 
Co-Immunoprecipitation (Co-IP) 43 
Analysis of protein-protein interaction was carried out using a previously published 44 
protocol5.  Briefly, after stimulation, cells were washed in ice-cold PBS followed by cell 45 
lysis with 300µl of Co-IP buffer (50mM HEPES, pH=7.8, 300mM NaCl, 1% NP-40, 46 
1.2mM EDTA pH=8.0, 5mM MgCl2 with protease inhibitors).  To the lysate, a total of 3-5 47 
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ml of the IP antibody was added followed by overnight incubation at 4oC.  The next day, 1 
the cell lysate was incubated with 20ml of equilibrated protein G beads for 2-3 hours at 2 
4oC.  The bead mixture was centrifuged and washed with Co-IP washing buffer (same as 3 
Co-IP buffer but with 0.1% NP-40).  The beads were then resuspended in Laemmli 4 
Buffer and boiled for five minutes, followed by western immunoblot analysis of the 5 
beads.  Loading was confirmed by western immunoblot for α-tubulin in a sample of the 6 
whole cell lysate obtained prior to addition of antibodies.  7 
 8 
Generation of the Δ ITGA3 and Integrin Chimeric Mutants 9 
For generation of the integrin chimeras, the cytoplasmic tail of α3 (3039G-3136A) and 10 
α4 (3129C-3225C) were excised from their native sequence and swapped followed by 11 
subcloning into a pcDNA 3.1 vector.  For the generation of the ITGA3 mutant (Δα3), we 12 
substituted the serines found in the QPSXXE motif with alanines as illustrated below: 13 
 14 
AGCCCAGCCGTCAGAGACAGA (Native Sequence) 15 
AGaCCAGCCGgCAGAGACcGA (Mutant Sequence) 16 
 17 
Site-directed mutagenesis and Chimera generation were performed at Mutagenex Labs 18 
(Mutagenex, Somerset, NJ). 19 
 20 
Statistical analysis 21 
The number of samples or animals studied per experiment is indicated in the Figure 22 
Legends.  Values from multiple experiments are expressed as mean±SEM.  Statistical 23 
significance was determined using unpaired t-test or one-way ANOVA followed by 24 
Dunnett’s or Bonferroni’s multiple comparison tests unless stated otherwise.  A value of 25 
P<0.05 was considered significant. 26 
 27 
 28 
 29 
 30 
 31 
 32 
 33 
 34 
 35 
 36 
 37 
 38 
 39 
 40 
 41 
 42 
 43 
 44 
 45 
 46 
 47 
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 22 
Supplement Figure I.  ApcMin/+ mice demonstrate no differences in 23 
echocardiographic parameters compared to C57 controls.    24 
 25 
(A) Left ventricular fractional shortening, (B) ejection fraction, (C) cardiac output 26 
and (D) heart rate of C57 littermate and ApcMin/+ mice in normoxia and chronic 27 
hypoxia.  (E) Systolic blood pressure was measured using a tail cuff method.  (F) 28 
Left ventricular end diastolic pressure (LVEDP) and (G) pulmonary artery 29 
aceleration times (PAAT) measurements were carried out as described in the 30 
Methods.  31 
32 
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Supplement Figure II.   βC knockdown does not promote survival in APC 6 
deficient human mvPAECs. 7 
 8 
(A) siRNA mediated βC knockdown and (B) caspase 3/7 activation assay in 9 
scrambled and βC siRNA treated C57 littermate and ApcMin/+ mvPAECs was 10 
performed as described in the Methods. Bars represent mean ±SEM from N=3 11 
experiments. **P<0.001, ***P<0.0001 vs. C57, one way ANOVA with Bonferroni’s 12 
post-test.  13 
14 
ApcMin/+ 
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Supplement Figure III.  APCMin/+ mvPAECs demonstrate reduced clustering 19 
of microtubule networks.   20 
 21 
Representative IF images of C57 (left panel) and APCMin/+ (right panel) 22 
mvPAECs probed for α-tubulin (red). Scale bar=50µm. 23 
 24 
 25 
 26 
 27 
 28 
 29 
 30 
 31 
 32 
 33 
 34 
 35 
 36 
 37 
 38 
 39 
 40 
 41 
 42 
 43 
 44 
 45 
 46 
CIRCRESAHA/2012/267849-R2, Online Supplement 
 
 11 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
 24 
 25 
 26 
 27 
 28 
Supplement Figure IV.  APC siRNA treated human mvPAECs demonstrate 29 
preserved proliferation response and reduced survival in hypoxia.  30 
 31 
(A) Cell count and (B) caspase 3/7 luciferase assay were performed as described 32 
in the Methods. Bars represent mean ±SEM from N=3 experiments. ***P<0.0001 33 
vs. scrambled siRNA control at baseline and #P<0.01, ##P<0.001 vs. 34 
corresponding scrambled siRNA mvPAECs, one way ANOVA with Bonferroni 35 
post-test.   36 
 37 
 38 
 39 
 40 
 41 
 42 
 43 
 44 
 45 
 46 
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Supplement Figure V.  Human mvPAECs bind to laminin via α3β1 integrins 1 
resulting in the formation of an α3/APC protein complex.   2 
 3 
(A) Adhesion to laminin (LN) in human mvPAECs pretreated with increasing 4 
concentrations of α and β integrin blocking antibodies was evaluated 30 minutes 5 
after seeding the cells. Cells incubated with nonspecific IgG served as controls.  6 
(B) Immunoprecipitation of whole cell lysates of mvPAECs recovered following 7 
adhesion to collagen IV (CIV), LN and fibronectin (FN) using  α1, α3 and α5 8 
integrin antibodies and immunoblotting using APC antibody. Bars represent 9 
mean ±SEM from N=3 experiments. *P<0.01, **P<0.001, ***P<0.0001 versus 10 
IgG, one way ANOVA with Bonferroni's post-test.  11 
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Supplement Figure VI.  APC and ILK-1 colocalize in the periphery of  6 
laminin adhered mvPAECs.   7 
 8 
Representative confocal images of C57 mvPAECs probed for APC (green) and 9 
ILK-1 (red).  Merged images are shown in the right panels.  Nuclei were stained 10 
blue with DAPI.  Scale bar=50µm. 11 
 12 
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Supplement Figure VII.  SW480 cells demonstrate reduced adhesion to 29 
laminin.   30 
 31 
Adhesion assay of SW480 cells seeded in collagen IV (CIV), laminin (LN) and 32 
fibronectin (FN). Bars represent mean ±SEM from N=3 experiments.*P<0.01, 33 
***P<0.0001, one way ANOVA with Bonferroni's post-test versus noncoated 34 
(NC).  35 
 36 
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 39 
 40 
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 42 
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 45 
 46 
 47 
 48 
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Supplement Figure VIII.  WT APC transfected human mvPAECs 13 
demonstrate increased survival in hypoxia.  14 
 15 
Caspase 3/7 luciferase assay were performed as described in the Methods. Bars 16 
represent mean ±SEM from N=3 experiments. ***P<0.0001 vs. normoxia control 17 
at baseline and #P<0.01, ##P<0.001 vs. corresponding normoxia mvPAECs, one 18 
way ANOVA with Bonferroni post-test.   19 
 20 
 21 
 22 
 23 
 24 
 25 
 26 
 27 
 28 
29 
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Supplement Figure IX.  IPAH mvPAECs recover adhesion to laminin after 37 
transfection with WT APC expression construct.   38 
 39 
Adhesion assay of IPAH mvPAECs cells seeded in collagen IV (CIV), laminin 40 
(LN) and fibronectin (FN). Bars represent mean ±SEM from N=3 41 
experiments.***P<0.0001 versus empty vector, one way ANOVA with 42 
Bonferroni's post-test.   43 
44 
80 
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Supplement Figure X.  APC expression is reduced in human mvPAECs 30 
incubated in hypoxia.   31 
 32 
Western immunoblot for APC in whole cell lysates of human mvPAECs exposed 33 
to normoxia (FiO2: 20%) and hypoxia (FiO2: 1%) for 24 hours. Densitometry 34 
values are shown relative α-tubulin in whole cell lysates.  ***P<0.0001, unpaired 35 
t-test. 36 
 37 
38 
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Supplement Figure XI.  Transfection of a constitutively active (CA) Akt 16 
construct fails to protect APC siRNA treated mvPAECs incubated under 17 
serum free consitions.   18 
 19 
Survival was measured using the Caspase 3/7 luciferase assay and results were 20 
compared against scrambled or APC siRNA treated mvPAECs transfected with 21 
an empty vector.  ###P<0.0001 vs. corresponding scrambled siRNA and *P<0.01 22 
vs. scrambled siRNA+empty vector, one way ANOVA with Bonferroni’s post-test.  23 
 24 
 25 
 26 
 27 
 28 
 29 
 30 
 31 
 32 
 33 
 34 
 35 
 36 
 37 
 38 
 39 
 40 
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Supplement Table I.  Clinical characteristics of the patients who served as the 2 
source for unused donor and IPAH mvPAECs.   3 
 4 
 5 
 6 
